SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense investor frustration as the stock continues a sharp, multi-week decline that has decoupled from broader market gains. The community is actively debating whether this represents an oversold buying opportunity, a structural shift due to mounting AI infrastructure costs and integration concerns, or deliberate algorithmic manipulation.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant attention from investors seeking exposure to high-growth private companies like SpaceX and Anthropic ahead of potential IPO activity. The community is actively debating the fund's portfolio concentration and its premium relative to net asset value, with many comparing it to other market participants as a strategic way to access unicorn investments.

The Shrimp Army

SHRIMPS is gaining momentum as part of a broader trend of ocean-themed memecoins, sparking intense community debate over its potential for rapid gains versus the risks of typical pump-and-dump volatility. Traders are actively comparing it to other ecosystem tokens while discussing strategies to capture momentum and eliminate zeros in the coin's price.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is trending following a massive 16% surge driven by a strategic pivot into fabless semiconductor manufacturing and the launch of its AGI CPU, which Wall Street expects to unlock significant high-margin revenue streams. Community sentiment is deeply divided between long-term bulls praising the company's vital role in the AI data center infrastructure and skeptical traders warning that the stock's high valuation is already priced in years ahead.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently trending as traders capitalize on a recent surge in CPU demand and price hikes, while simultaneously weighing the stock against broader semiconductor sector volatility and ongoing geopolitical uncertainties. Community sentiment remains split between bullish AI-driven conviction and cautious hedging, with active debate regarding potential gap fills and short-term volatility.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is trending as investors debate the sustainability of massive AI-driven capital expenditures and monitor potential regulatory and operational risks from geopolitical tensions. The community is actively discussing Google's competitive position in the cloud and AI landscape, specifically regarding its integration of Gemini into government networks and utility-backed data center partnerships.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is currently experiencing high volatility following a short report from Culper Research alleging accounting irregularities and channel stuffing, which the company has formally rejected as false and misleading. While the market reaction has been sharp, the community remains divided, with long-term investors highlighting the firm's growth trajectory and aggressive share repurchase program as evidence of management's confidence and fundamental strength.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is currently the focal point of intense market debate as investors grapple with its aggressive capital-raising strategy and heavy reliance on Bitcoin accumulation. The community is sharply divided, with bulls pointing to the company's long-term Bitcoin treasury strategy as a high-conviction play, while skeptical traders and bears emphasize the risks of ongoing share dilution and the stock's high volatility relative to broader market movements.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillow is trending as the market closely monitors the intersection of shifting housing policy, potential Fed rate cuts, and evolving AI-driven search dynamics, while investors actively debate whether the stock offers long-term platform dominance compared to emerging real estate tech competitors. Community discussion remains polarized, featuring both retail investors betting on a rebound as affordability measures improve and frustrated users sharing negative experiences with property management and listing accuracy.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending following the announcement that it will deploy its Gemini AI agents across the Pentagon's massive workforce, signaling a significant expansion of its defense sector footprint. Investors are closely monitoring this government integration alongside the company's aggressive infrastructure spending and ongoing competitive AI battles with industry rivals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears

Abivax plans fundraising after June trial data as CEO signals no urgency to sell amid takeover speculation and strong stock momentum.read more...

Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC

Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers...

Barclays Raises Abivax (NASDAQ:ABVX) Price Target to $148.00

Barclays upped their price target on Abivax from $142.00 to $148.00 and gave the stock an "overweight" rating in a report on Tuesday...

Abivax (NASDAQ:ABVX) Announces Earnings Results

Abivax (NASDAQ:ABVX - Get Free Report) issued its quarterly earnings results on Monday. The company reported ($1.24) earnings per share for the quarter, topping the consensus estimate of ($2.24) by...

Hudson Bay Capital Management LP Makes New Investment in Abivax SA Sponsored ADR $ABVX

Hudson Bay Capital Management LP purchased a new stake in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 91,062 shares of the company's stock, valued a...

35,000 Shares in Abivax SA Sponsored ADR $ABVX Bought by Cantor Fitzgerald L. P.

Cantor Fitzgerald L. P. acquired a new stake in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 35,000 shares of the company's stock, valued at approximately $2...

Holocene Advisors LP Buys Shares of 461,301 Abivax SA Sponsored ADR $ABVX

Holocene Advisors LP bought a new stake in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and...

Top Biotech Stocks To Keep An Eye On - March 16th

Danaher, Vertex Pharmaceuticals, Moderna, BioCryst Pharmaceuticals, ImmunityBio, argenex, and Abivax are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Abivax (NASDAQ:ABVX) Now Covered by Jefferies Financial Group

Jefferies Financial Group assumed coverage on Abivax in a research note on Monday. They set a "buy" rating and a $160.00 target price for the company...

HighVista Strategies LLC Raises Holdings in Abivax SA Sponsored ADR $ABVX

HighVista Strategies LLC boosted its holdings in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) by 260.6% during the 3rd quarter, according to the company in its most recent disclosure with the...

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Current Price	$110.70
Prev Close	$110.17
Open	$112.00
Dividend Yield	0.00%
50-Day Moving Average	$118.88
Beta	0.78
Avg. Volume	799,719.86
PE Ratio	-20.48

52-Week High	$148.83
52-Week Low	$4.77
Market Capitalization	$8.76B
EPS (Annual)	-$5.46
Price to Book	16.26
Revenue Per Employee	$0.00

ABVX
Abivax - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABVX News

ABVXAbivax - ADR